Acceptance of standardized ultrasound classification, use of albendazole, and long-term follow-up in clinical management of cystic echinococcosis : a systematic review
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 2713988
Author(s) Tamarozzi, Francesca; Nicoletti, Giovanni J.; Neumayr, Andreas; Brunetti, Enrico
Author(s) at UniBasel Neumayr, Andreas
Year 2014
Title Acceptance of standardized ultrasound classification, use of albendazole, and long-term follow-up in clinical management of cystic echinococcosis : a systematic review
Journal Current Opinion in Infectious Diseases
Volume 27
Number 5
Pages / Article-Number 425-431
Keywords albendazole, classification, cystic echinococcosis, follow-up, hydatid cyst stages, systematic review, WHO Informal Working Group on Echinococcosis
Mesh terms Albendazole, therapeutic use; Anthelmintics, therapeutic use; Drainage; Echinococcosis, Hepatic, drug therapy; Follow-Up Studies; Hepatectomy; Humans; Neglected Diseases, drug therapy; Ultrasonography, Interventional; World Health Organization
Abstract Cystic echinococcosis is a chronic, complex, and neglected disease. The need for a simple classification of cyst morphology that would provide an accepted framework for scientific and clinical work on cystic echinococcosis has been addressed by two documents issued by the WHO Informal Working Group on Echinococcosis in 2003 (cyst classification) and in 2010 (Expert consensus for the diagnosis and treatment of echinococcosis).; Here we evaluate the use of the WHO Informal Working Group on Echinococcosis classification of hepatic cystic echinococcosis, the acceptance by clinicians of recommendations regarding the use of albendazole, and the implementation of the long-term follow-up of patients with hepatic cystic echinococcosis in the scientific literature since the WHO Informal Working Group on Echinococcosis recommendations were issued.; Of the publications included in our review, 71.2% did not indicate any classification, whereas 14% used the WHO Informal Working Group on Echinococcosis classification. Seventy-four percent reported the administration of peri-interventional albendazole, although less than half reported its modality, and 51% the length of patient follow-up. A joint effort is needed from the scientific community to encourage the acceptance and implementation of these three key issues in the clinical management of cystic echinococcosis.
Publisher Lippincott, Williams & Wilkins
ISSN/ISBN 0951-7375 ; 1473-6527
edoc-URL http://edoc.unibas.ch/dok/A6298958
Full Text on edoc Available
Digital Object Identifier DOI 10.1097/QCO.0000000000000093
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/25101556
ISI-Number WOS:000348384400004
Document type (ISI) Review
 
   

MCSS v5.8 PRO. 0.466 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
15/08/2020